Clinical Trial Update: Buprenorphine Dose Alteration Study - 1 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating dosing adjustments of buprenorphine for opioid use disorder has completed, conducted by the University of Vermont.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Vermont | Conditions: Opioid-Related Disorders | Phase 1 | Status: COMPLETED